Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 222 results for "cadila healthcare"

Pharma duo settle patent row in US

(PTI): Cadila Healthcare and Zydus Pharmaceuticals today said they had entered into a settlement agreement with Depomed Inc in a patent infringement row. The case is related to Depomeds neuropathic pain relieving drug Gralise. Cadila Healthcare and Zydus ... The Telegraph, 2 days ago

36 images for cadila healthcare, 2 weeks ago, 3 weeks ago
Oneindia, 1 month ago, 1 month ago
Financial Express, 2 months ago
Financial Express, 2 months ago, 1 month ago
Money Today, 2 months ago, 2 months ago, 1 month ago

Cadila, Depomed settle case on gapapentin

MUMBAI: Ahmedabad-based Cadila Healthcare (Zydus Cadila) and Zydus Pharmaceuticals Inc, a generic pharma company in the US, announced that they have entered into a settlement agreement with Depomed, Inc to settle their ongoing patent infringement ...
 Times of India3 days ago Cadila, Depomed Inc settle patent dispute  Smart Investor3 days ago CADILA, DEPOMED SETTLE PATENT CASE  Pharmacy Choice13 hours ago Cadila, Depomed settle US patent dispute on neuro pain drug Gralise  Livemint.com3 days ago
Money Control

Cadila Healthcare gains on entering into settlement agreement with Depomed on Gralise

Cadila Healthcare is currently trading at Rs. 984.70, up by 17.80 points or 1.84 % from its previous closing of Rs. 966.90 on the BSE. The scrip opened at Rs. 986.50 and has touched a high and low of Rs. 994.50 and Rs. 966.00 respectively. So far ...
 Indian-Commodity3 days ago Cadila Healthcare Limited settles patent litigation with Depomed on Gralise┬«  Equity Bulls2 days ago Cadila Healthcar - Cadila Healthcare Limited Announces Settl...  SBICAP Securities3 days ago ZYDUS -Cadila Healthcare Limited Announces Settlement with Depomed on Gralise  Pharmacy Choice2 days ago

New Market Study Published: Dyslipidemia - Pipeline Review, H1 2014

New Pharmaceuticals research report from Global Markets Direct is now available from Boston, MA -- (SBWIRE) -- 04/18/2014 -- Global Markets Direct's, 'Dyslipidemia - Pipeline Review, H1 2014', provides an overview of the Dyslipidemia's therapeutic ...
 Digital Journal4 hours ago New Market Study, "Osteoporosis - Pipeline Review, H1 2014", Has Been Published  Digital Journal2 days ago Rheumatoid Arthritis - Pipeline Review, H1 2014: New Research Report Available at Fast Market Research  Digital Journal2 days ago
Business Standard India

Pharma Sector Expects Strong FY15

body: The country's pharmaceutical industry expects to be back on a strong growth path in 2014-15, after a tough year battling price control and trade issues. On the whole, it expects growth of 12-14 percent. Pankaj Patel, chairman and managing ...
 AAPS Pharmceutica1 day ago

Indian markets drift lower

Posted by Equitymaster In the post noon session, the Indian indices have drifted into the red. There is broad based selling on the bourses. Apart from the FMCG index all other sectoral indices are trading below the dotted line. The BSE-Sensex is trading down ...
 Equitymaster.com2 days ago Indian share markets slip further  Equitymaster.com1 week ago India share markets remain buoyant  Equitymaster.com1 month ago Indian share markets remain volatile  Equitymaster.com1 month ago

Global Veterinary Vaccines Industry

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product Segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry ...
 Yahoo! Finance3 days ago Research and Markets Adds Report: Global Pharmaceutical and Biotechnology Outlook 2014 - India Pharma  Individual.com2 weeks ago Research and Markets Adds Report: 'Global Generic Drugs Market 2014-2018'  Individual.com3 weeks ago

Realty, metal stocks lead fall

Increase in global crude oil prices and weak domestic macroeconomic data weighed on Indian stocks on the first trading session of the week. The market breadth, indicating health of the market was negative. The barometer index, the S&P BSE Sensex , ...
 Business Standard India3 days ago

Raking in the dollar

For the last 3-4 quarters, investors betting on non-India plays or export-oriented sectors such as IT, pharma and even Tata Motors were well rewarded due to fall in rupee value vis-à-vis the dollar. The story may stay unchanged for exporters in the ...
 Financial Chronicle4 days ago

Global stock markets end in red

Posted by Equitymaster During the week gone by, US stocks suffered their largest weekly decline since January as investors sold companies with especially high valuations and braced themselves for a disappointing corporate earnings season. The Federal Reserve ...
 Equitymaster.com6 days ago Global markets remain upbeat  Equitymaster.com1 month ago A good week for global markets  Equitymaster.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less